Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 18/12/20131 min de lecture
Pilot Program for Parallel Review of Medical Products; Extension of the Duration of the Program
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) (the Agencies) are announcing the extension of the "Pilot Program for Parallel Review of Medical Products." The Agencies have decided to continue the program as currently designed for an additional period of 2 years from the date of publication of this notice.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →